In the interest of full disclosure, ICSI has adopted the policy of revealing relationships work group members have with companies that sell products or services that are relevant to this guideline topic. The reader should not assume that these financial interests will have an adverse impact on the content of the guideline, but they are noted here to fully inform readers. Readers of the guideline may assume that only work group members listed below have potential conflicts of interest to disclose. Steven L. Kopecky MD is a consultant for Bayer, Fibrex, ParinGenix, Pinnacle Care, Prime Therapeutics and has received grant research support from AtherGenics, Integrium and Reliant. Patrick J. O'Connor MD has received research funding from AHRQ, NHLBI, NIPPIS and NIA. All grant monies go to the HealthPartners Research Foundation. He also is a member of American Diabetes Association No other work group members have potential conflicts of interest to disclose. ICSI's conflict of interest policy and procedures are available for review on ICSI's Web site at http://www.icsi.org. |